Key result
Rheumatic heart disease care relies on long-term prophylaxis, anticoagulation, and timely valve interventions.
Why the study?
Gaps persist in understanding optimal medical and surgical treatment strategies for rheumatic heart disease, partly due to limited research investment in endemic regions.
This review provides a comprehensive overview of the medical, interventional, and surgical management of rheumatic heart disease, emphasizing the critical need for improved healthcare access and research in resource-limited settings.
No takes yet. Share an insight, caveat, or question.
Persistent access barriers hinder RHD management in endemic regions; leaves open critical evidence gaps for targeted research.
Klassen et al. (2026) conducted a review in Rheumatic heart disease. Medical, interventional, and surgical management was evaluated. Management of rheumatic heart disease relies on sustained secondary prophylaxis, anticoagulation for atrial fibrillation, and timely surgical or transcatheter interventions, though evidence gaps and access barriers persist.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: